Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Combining Neurobiology and New Learning: Ketamine and Prolonged Exposure: A Potential Rapid Treatment for Post Traumatic Stress Disorder (PTSD)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02727998

Organisation Name: Yale University

Overal Status: Terminated

Start Date: December 2015

Last Update: October 17, 2022

Lead Sponsor: Yale University

Brief Summary: The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.

Conditions:
  • Posttraumatic Stress Disorder


Total execution time in seconds: 0.63462018966675